| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |